Anticoagulation therapy in pulmonary arterial hypertension

Satoshi Akagi, Kengo Fukushima Kusano

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Vascular thrombosis implicates in the pathogenesis of pulmonary arterial hypertension (PAH). Anticoagulation therapy (warfarin) has been recommended by many experts in the treatment of PAH. However, the long-term effectiveness of anticoagulation therapy remains controversial. Because of the various drugs, such as epoprostenol, bosentan, and sildenafil, for the treatment of PAH recently, warfarin alone is not a realistic therapy for PAH. Accordingly we reviewed the previous manuscript regarding anticoagulation therapy for PAH, and looked at the current role of anticoagulation therapy in Japan.

Original languageEnglish
Pages (from-to)2174-2178
Number of pages5
JournalNihon rinsho. Japanese journal of clinical medicine
Volume66
Issue number11
Publication statusPublished - Nov 2008

Fingerprint

Pulmonary Hypertension
Warfarin
Therapeutics
Manuscripts
Epoprostenol
Blood Vessels
Japan
Thrombosis
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Anticoagulation therapy in pulmonary arterial hypertension. / Akagi, Satoshi; Kusano, Kengo Fukushima.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 66, No. 11, 11.2008, p. 2174-2178.

Research output: Contribution to journalArticle

@article{8e8953daf3d54ee69e30124376109b37,
title = "Anticoagulation therapy in pulmonary arterial hypertension",
abstract = "Vascular thrombosis implicates in the pathogenesis of pulmonary arterial hypertension (PAH). Anticoagulation therapy (warfarin) has been recommended by many experts in the treatment of PAH. However, the long-term effectiveness of anticoagulation therapy remains controversial. Because of the various drugs, such as epoprostenol, bosentan, and sildenafil, for the treatment of PAH recently, warfarin alone is not a realistic therapy for PAH. Accordingly we reviewed the previous manuscript regarding anticoagulation therapy for PAH, and looked at the current role of anticoagulation therapy in Japan.",
author = "Satoshi Akagi and Kusano, {Kengo Fukushima}",
year = "2008",
month = "11",
language = "English",
volume = "66",
pages = "2174--2178",
journal = "Nippon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "11",

}

TY - JOUR

T1 - Anticoagulation therapy in pulmonary arterial hypertension

AU - Akagi, Satoshi

AU - Kusano, Kengo Fukushima

PY - 2008/11

Y1 - 2008/11

N2 - Vascular thrombosis implicates in the pathogenesis of pulmonary arterial hypertension (PAH). Anticoagulation therapy (warfarin) has been recommended by many experts in the treatment of PAH. However, the long-term effectiveness of anticoagulation therapy remains controversial. Because of the various drugs, such as epoprostenol, bosentan, and sildenafil, for the treatment of PAH recently, warfarin alone is not a realistic therapy for PAH. Accordingly we reviewed the previous manuscript regarding anticoagulation therapy for PAH, and looked at the current role of anticoagulation therapy in Japan.

AB - Vascular thrombosis implicates in the pathogenesis of pulmonary arterial hypertension (PAH). Anticoagulation therapy (warfarin) has been recommended by many experts in the treatment of PAH. However, the long-term effectiveness of anticoagulation therapy remains controversial. Because of the various drugs, such as epoprostenol, bosentan, and sildenafil, for the treatment of PAH recently, warfarin alone is not a realistic therapy for PAH. Accordingly we reviewed the previous manuscript regarding anticoagulation therapy for PAH, and looked at the current role of anticoagulation therapy in Japan.

UR - http://www.scopus.com/inward/record.url?scp=58149474644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149474644&partnerID=8YFLogxK

M3 - Article

VL - 66

SP - 2174

EP - 2178

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 11

ER -